Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05521438 · ClinicalTrials.gov registry record · Phase 2

Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton Syndrome

A Phase 2 study of Netherton Syndrome, sponsored by Quoin Pharmaceuticals.

Active
Registry status
Phase 2
Development phase
30
Enrollment target
5
Study locations

NCT05521438 is a Phase 2 study of Netherton Syndrome that is active but no longer recruiting, run by Quoin Pharmaceuticals. The registered enrollment target is 30 participants, above the 24-participant average among 6 other Netherton Syndrome trials with a reported enrollment target (25% higher). The trial reports 5 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05521438, a Phase 2 study of Netherton Syndrome, is active but no longer recruiting, sponsored by Quoin Pharmaceuticals.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
30 participants
Enrollment target
5
Study locations

Study Summary

This study has been designed to determine the safety, tolerability and efficacy of QRX003 lotion 2%, 4% QAM or 4% BID in subjects with Netherton Syndrome (NS) in comparison to vehicle

Conditions Studied

Netherton Syndrome

Interventions

  • DRUG Vehicle
  • DRUG QRX003-2% Lotion
  • DRUG QRX003-4% Lotion QAM
  • DRUG QRX003-4% Lotion BID

Study Locations (5)

California

  • Site #1 - San Diego

Indiana

  • Site #4 - Indianapolis

Massachusetts

  • Site #5 - Quincy

South Carolina

  • Site #3 - Charleston

Texas

  • Site #2 - San Antonio

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2022-06-23
Est. Completion 2026-12-31
Phase Phase 2

Sponsor

Quoin Pharmaceuticals

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05521438

The ClinicalTrials.gov registry entry for NCT05521438 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 24-participant average among 6 other Netherton Syndrome trials with a reported enrollment target (25% higher). The listed sponsor is Quoin Pharmaceuticals, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Netherton Syndrome appearing as the primary indexed condition, and to 4 interventions - of which Vehicle is the first listed.

NCT05521438 reports 5 study locations spanning 5 distinct geographic areas - top geographies include California, Indiana, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05521438 about?

NCT05521438 is a clinical study titled "Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton Syndrome". This study has been designed to determine the safety, tolerability and efficacy of QRX003 lotion 2%, 4% QAM or 4% BID in subjects with Netherton Syndrome (NS) in comparison to vehicle

What is the current status of trial NCT05521438?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2022-06-23. Estimated completion is 2026-12-31.

What conditions does trial NCT05521438 study?

This clinical trial studies the following conditions: Netherton Syndrome.

What interventions are being tested in trial NCT05521438?

The interventions under investigation include: Vehicle (DRUG), QRX003-2% Lotion (DRUG), QRX003-4% Lotion QAM (DRUG), QRX003-4% Lotion BID (DRUG).

Who is sponsoring clinical trial NCT05521438?

This trial is sponsored by Quoin Pharmaceuticals, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05521438 being conducted?

This trial has 5 study locations across California, Indiana, Massachusetts, South Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Netherton Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Netherton Syndrome

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.